Changes in total plasma and serum N-glycome composition and patient-controlled analgesia after major abdominal surgery

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Gudelj, Ivan ^a   Baciarello, Marco ^b,c,d   Ugrina, Ivo ^a,e   De Gregori, Manuela ^c,f,g   Napolioni, Valerio ^c,h   Ingelmo, Pablo M ^c,i   Bugada, Dario ^b,c,d   De Gregori, Simona ^f   Derek, Lovorka ^j   Pučić Baković, Maja ^a   Novokmet, Mislav ^a   Gornik, Olga ^e   Saccani Jotti, Gloria ^d   Meschi, Tiziana ^d   Lauc, Gordan ^a,e   Allegri, Massimo ^b,c,d  

^a GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

^c SIMPAR (Study in Multidisciplinary Pain Research Group)   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

^e UNIVERSITY OF ZAGREB   (Croatia)

^f FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^g Young Against Pain (YAP) Group   (Italy)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ MONTREAL CHILDREN S HOSPITAL   (Canada)

^j University of Zagreb   (Croatia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FUCOSE; PLASMA PROTEIN; POLYSACCHARIDE; SIALIC ACID DERIVATIVE;

ABDOMEN; ADULT; AGED; BLOOD; CHEMISTRY; COHORT ANALYSIS; FEMALE; GLYCOBIOLOGY; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; PATIENT CONTROLLED ANALGESIA; SERUM; SURGERY; YOUNG ADULT;

ABDOMEN; ADULT; AGED; ANALGESIA, PATIENT-CONTROLLED; BLOOD PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; FEMALE; FUCOSE; GLYCOMICS; GLYCOSYLATION; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; POLYSACCHARIDES; SERUM; SIALIC ACIDS; SURGICAL PROCEDURES, OPERATIVE; YOUNG ADULT;

EID: 84981215205     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31234     Document Type: Article

References (60)

1. Gornik, O., Pavic, T. & Lauc, G. Alternative glycosylation modulates function of IgG and other proteins - implications on evolution and disease. Biochim. Biophys. Acta 1820, 1318-1326 (2012).
2. Lauc, G., Vojta, A. & Zoldoš, V. Epigenetic regulation of glycosylation is the quantum mechanics of biology. Biochim. Biophys. Acta-Gen. Subj. 1840, 65-70 (2014).
3. Lauc, G., Krištić, J. & Zoldoš, V. Glycans-the third revolution in evolution. Front. Genet. 5, 1-7 (2014).
4. Parekh, R. B. et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316, 452-457 (1985).
5. National Research Council. Transforming Glycoscience: A Roadmap for the Future. Books (2012).
6. Wolfert, M. A. & Boons, G.-J. Adaptive immune activation: glycosylation does matter. Nat Chem Biol 9, 776-784 (2013).
7. Arnold, J. N., Saldova, R., Abd Hamid, U. M. & Rudd, P. M. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic infammation. Proteomics 8, 3284-3293 (2008).
8. Reis, C. a, Osorio, H., Silva, L., Gomes, C. & David, L. Alterations in glycosylation as biomarkers for cancer detection. J. Clin. Pathol. 63, 322-329 (2010).
9. Raja, S. G. & Dreyfus, G. D. Modulation of systemic infammatory response afer cardiac surgery. Asian Cardiovasc. Torac. Ann. 13, 382-395 (2005).
10. Rittner, H. L., Brack, A. & Stein, C. Pain and the immune system. British Journal of Anaesthesia 101, 40-44 (2008).
11. Bugada, D. et al. Efect of Preoperative Infammatory Status and Comorbidities on Pain Resolution and Persistent Postsurgical Pain afer Inguinal Hernia Repair. Mediators of Infammation 2016, 1-7 (2016).
12. Wu, C. L. & Raja, S. N. Treatment of acute postoperative pain. Lancet 377, 2215-2225 (2011).
13. De Gregori, M. et al. Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain. Eur. J. Clin. Pharmacol. 69, 1651-1658 (2013)
14. Ren, Z. Y. et al. The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis. Pain Physician 18, 131-152 (2015).
15. Hwang, I. C. et al. OPRM1 A118G Gene Variant and Postoperative Opioid Requirement: A Systematic Review and Meta-analysis. Anesthesiology 121, 825-834 (2014).
16. Knezevic, A. et al. Variability, Heritability and Environmental Determinants of Human Plasma N-Glycome Variability. J. Proteome Res. 8, 694-701 (2009).
17. Pucic, M. et al. High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics 10, M111, 010090 (2011).
18. Vučković, F. et al. Systemic lupus erythematosus associates with the decreased immunosuppressive potential of the IgG glycome. Arthritis Rheumatol. (Hoboken, N.J.) 67, 2978-2989 (2015).
19. Tanabalasingham, G. et al. Mutations in HNF1A result in marked alterations of plasma glycan profle. Diabetes 62, 1329-1337 (2013).
20. Novokmet, M. et al. Changes in IgG and total plasma protein glycomes in acute systemic infammation. Sci. Rep. 4, 1-10 (2014).
21. Trbojević Akmačić, I. et al. Infammatory Bowel Disease Associates with Proinfammatory Potential of the Immunoglobulin G Glycome. Infamm. Bowel Dis. 21, 1 (2015).
22. Vanhooren, V. et al. N-glycomic changes in serum proteins during human aging. Rejuvenation Res. 10, 521-531a (2007).
23. Kalf, J. C. et al. Biphasic response to gut manipulation and temporal correlation of cellular infltrates and muscle dysfunction in rat. Surgery 126, 498-509 (1999).
24. Cruickshank, A., Fraser, W. , Burns, H., Van Damme, J. & Shenkin, A. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci 79, 161-165 (1990).
25. Gonzalez-Quintela, A. et al. Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin. Exp. Immunol. 151, 42-50 (2007).
26. Shenkin, A. et al. The serum interleukin 6 response to elective surgery. Lymphokine Res. 8, 123-127 (1989).
27. Castell, J. V. et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 242, 237-239 (1989).
28. Ohzato, H. et al. Interleukin-6 as a new indicator of infammatory status: detection of serum levels of interleukin-6 and C-reactive protein afer surgery. Surgery 111, 201-209 (1992).
29. Lauc, G. et al. Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers. PLoS Genet. 9, e1003225 (2013).
30. Gornik, O. et al. Stability of N-glycan profles in human plasma. Glycobiology 19, 1547-1553 (2009).
31. EC, B. der L., de Haan, P. F., Havenaar, E. C. & Van, D. W. Infammation-induced expression of sialyl LewisX is not restricted to alpha1-acid glycoprotein but also occurs to a lesser extent on alpha1-antichymotrypsin and haptoglobin. Glycoconj. J. 15, 177-182 (1998).
32. Sperandio, M. Selectins and glycosyltransferases in leukocyte rolling in vivo. FEBS J. 273, 4377-4389 (2006).
33. Lowe, J. B. Glycosylation in the control of selectin counter-receptor structure and function. Immunol. Rev. 186, 19-36 (2002).
34. Mitoma, J. et al. Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitment. Nat. Immunol. 8, 409-418 (2007).
35. Miwa, H. E., Song, Y., Alvarez, R., Cummings, R. D. & Stanley, P. The bisecting GlcNAc in cell growth control and tumor progression. Glycoconj. J. 29, 609-618 (2012).
36. Tirumalai, R. S. Characterization of the Low Molecular Weight Human Serum Proteome. Mol. Cell. Proteomics 2, 1096-1103 (2003).
37. Dage, J. L., Ackermann, B. L. & Halsall, H. B. Site localization of sialyl Lewis(x) antigen on alpha1-acid glycoprotein by high performance liquid chromatography-electrospray mass spectrometry. Glycobiology 8, 755-760 (1998).
38. Imre, T. et al. Mass spectrometric and linear discriminant analysis of N-glycans of human serum alpha-1-acid glycoprotein in cancer patients and healthy individuals. J. Proteomics 71, 186-197 (2008).
39. Kolarich, D., Weber, A., Turecek, P. L., Schwarz, H. P. & Altmann, F. Comprehensive glyco-proteomic analysis of human alpha-1-antitrypsin and its charge isoforms. Proteomics 6, 3369-3380 (2006).
40. Mills, K. et al. Identifcation of alpha-1-antitrypsin variants in plasma with the use of proteomic technology. Clin. Chem. 47, 2012-2022 (2001).
41. Nilsson, J. et al. Enrichment of glycopeptides for glycan structure and attachment site identifcation. Nat. Methods 6, 809-811 (2009).
42. Hwang, H. et al. In-depth analysis of site-specifc N-glycosylation in vitro nectin from human plasma by tandem mass spectrometry with immunoprecipitation. Anal. Bioanal. Chem. 406, 7999-8011 (2014).
43. Harazono, A. et al. Site-specifc N-glycosylation analysis of human plasma ceruloplasmin using liquid chromatography with electrospray ionization tandem mass spectrometry. Anal. Biochem. 348, 259-268 (2006).
44. Clerc, F. et al. Human plasma protein N-glycosylation. Glycoconj. J., doi: 10.1007/s10719-015-9626-2 (2015).
45. Satomi, Y., Shimonishi, Y. & Takao, T. N-glycosylation at Asn(491) in the Asn-Xaa-Cys motif of human transferrin. FEBS Lett. 576, 51-56 (2004).
46. Satomi, Y., Shimonishi, Y., Hase, T. & Takao, T. Site-specifc carbohydrate profling of human transferrin by nano-fow liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 18, 2983-2988 (2004).
47. Wilson, N. L., Schulz, B. L., Karlsson, N. G. & Packer, N. H. Sequential analysis of N- and O-linked glycosylation of 2D-PAGE separated glycoproteins. J. Proteome Res. 1, 521-529 (2002).
48. Arnold, J. N. et al. Interaction of mannan binding lectin with alpha2 macroglobulin via exposed oligomannose glycans: a conserved feature of the thiol ester protein family? J. Biol. Chem. 281, 6955-6963 (2006).
49. Reiding, K. R., Blank, D., Kuijper, D. M., Deelder, A. M. & Wuhrer, M. High-throughput profling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specifc sialic acid esterifcation. Anal. Chem. 86, 5784-5793 (2014).
50. Adamczyk, B., Struwe, W. B., Ercan, A., Nigrovic, P. A. & Rudd, P. M. Characterization of fbrinogen glycosylation and its importance for serum/plasma N-glycome analysis. J. Proteome Res. 12, 444-454 (2013).
51. Zhang, S., Jiang, K., Sun, C., Lu, H. & Liu, Y. Quantitative analysis of site-specifc N-glycans on sera haptoglobin β chain in liver diseases. Acta Biochim. Biophys. Sin. (Shanghai) 45, 1021-1029 (2013).
52. Pompach, P. et al. Site-specifc glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma. Mol. Cell. Proteomics 12, 1281-1293 (2013).
53. van Dijk, W., Havenaar, E. C. & Brinkman-van der Linden, E. C. Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function. Glycoconj. J. 12, 227-233 (1995).
54. Brinkman-van der Linden, E. C., van Ommen, E. C. & van Dijk, W. Glycosylation of alpha 1-acid glycoprotein in septic shock: changes in degree of branching and in expression of sialyl Lewis(x) groups. Glycoconj. J. 13, 27-31 (1996).
55. Havenaar, E. C. et al. Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in alpha3-fucosylation of alpha1-acid glycoprotein. Glycoconj J 15, 723-729 (1998).
56. JM, W. , Fournet, B., Konan, D., Biou, D. & Durand, G. 400-MHz 1H-NMR spectroscopy of fucosylated tetrasialyl oligosaccharides isolated from normal and cirrhotic alpha 1-acid glycoprotein. FEBS Lett. 238, 390-394 (1988).
57. De Gregori, M. et al. Human Genetic Variability Contributes to Postoperative Morphine Consumption. J. Pain 17, 628-636 (2016).
58. Trbojević Akmačić, I. et al. High Troughput Glycomics: Optimization of Sample Preparation. Biochem. 80, 934-942 (2015).
59. Bates, D., Mächler, M., Bolker, B. & Walker, S. Fitting Linear Mixed-Efects Models Using lme4. J. Stat. Sofw. 67 (2015).
60. Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B (Methodological) 57, 289-300 (1995).